IES950586A2 - Pharmaceutical processing - Google Patents
Pharmaceutical processingInfo
- Publication number
- IES950586A2 IES950586A2 IES950586A IES950586A2 IE S950586 A2 IES950586 A2 IE S950586A2 IE S950586 A IES950586 A IE S950586A IE S950586 A2 IES950586 A2 IE S950586A2
- Authority
- IE
- Ireland
- Prior art keywords
- active pharmaceutical
- direct compression
- inhibitor
- pharmaceutical processing
- compression lactose
- Prior art date
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 238000007907 direct compression Methods 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 239000008101 lactose Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- ZKNJEOBYOLUGKJ-ALCCZGGFSA-N (z)-2-propylpent-2-enoic acid Chemical compound CCC\C(C(O)=O)=C\CC ZKNJEOBYOLUGKJ-ALCCZGGFSA-N 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960002016 oxybutynin chloride Drugs 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 229940069328 povidone Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Tablets are produced by directly compressing a mixture formed by dry blending an active pharmaceutical agent such as oxybutynin chloride, direct compression lactose, a lubricant such as magnesium stearate and an inhibitor such as a cross povidone based product. The inhibitor prevents interaction between the direct compression lactose and the active pharmaceutical ingredient.
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IES950586 IES65615B2 (en) | 1995-07-31 | 1995-07-31 | Pharmaceutical processing |
| PT95942265T PT800384E (en) | 1994-12-14 | 1995-12-14 | METHOD FOR PREPARING A PHARMACEUTICAL TABLET |
| EP00115840A EP1057479A1 (en) | 1994-12-14 | 1995-12-14 | Pharmaceutical tablet formulations for direct compression |
| ES95942265T ES2154744T3 (en) | 1994-12-14 | 1995-12-14 | FORMULATIONS OF PHARMACEUTICAL TABLETS FOR DIRECT COMPRESSION. |
| DE69520292T DE69520292T2 (en) | 1994-12-14 | 1995-12-14 | PHARMACEUTICAL PREPARATION FOR DIRECT INJECTION |
| IE950946A IE950946A1 (en) | 1994-12-14 | 1995-12-14 | Pharmaceutical tablet formulations. |
| EP95942265A EP0800384B1 (en) | 1994-12-14 | 1995-12-14 | Pharmaceutical tablet formulations for direct compression |
| AT95942265T ATE199495T1 (en) | 1994-12-14 | 1995-12-14 | PHARMACEUTICAL PREPARATION FOR DIRECT COMPRESSION |
| GB9525598A GB2295966B (en) | 1994-12-14 | 1995-12-14 | Direct compression tablets |
| PCT/IE1995/000062 WO1996018386A1 (en) | 1994-12-14 | 1995-12-14 | Pharmaceutical tablet formulations for direct compression |
| AU43539/96A AU4353996A (en) | 1994-12-14 | 1995-12-14 | Pharmaceutical tablet formulations for direct compression |
| DK95942265T DK0800384T3 (en) | 1994-12-14 | 1995-12-14 | Pharmaceutical tablet formulations for direct compression |
| GR20010400714T GR3035863T3 (en) | 1994-12-14 | 2001-05-15 | Pharmaceutical tablet formulations for direct compression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IES950586 IES65615B2 (en) | 1995-07-31 | 1995-07-31 | Pharmaceutical processing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IES950586A2 true IES950586A2 (en) | 1995-11-01 |
| IES65615B2 IES65615B2 (en) | 1995-11-01 |
Family
ID=11040836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IES950586 IES65615B2 (en) | 1994-12-14 | 1995-07-31 | Pharmaceutical processing |
Country Status (1)
| Country | Link |
|---|---|
| IE (1) | IES65615B2 (en) |
-
1995
- 1995-07-31 IE IES950586 patent/IES65615B2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IES65615B2 (en) | 1995-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2280628A1 (en) | Soft chewable tablets | |
| MX9602683A (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances. | |
| MY111754A (en) | Sustained release durg formulation containing a tramadol salt | |
| MY111879A (en) | Pharmaceutical formulations. | |
| FI942092A7 (en) | Government-approved product | |
| AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
| CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
| EP0840606A4 (en) | ||
| MY113908A (en) | Rapidly disintegrating formulation comprising tramadol or a tramadol salt | |
| AU4871797A (en) | Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it | |
| GEP20033062B (en) | Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative | |
| BG103714A (en) | Pararacetamol-containing tablet | |
| CA2110166A1 (en) | Tableting of colestipol hydrochloride | |
| AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
| NZ319138A (en) | Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi | |
| BR9609208A (en) | Dry granulation compressed granules or tablets and dry granulation compressed granules or tablets comprising desogestrel | |
| AU2001289849A1 (en) | Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| GB2295966B (en) | Direct compression tablets | |
| MY113431A (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| ATE173399T1 (en) | SUSTAINED-RELEASE TABLET CONTAINING DICLOFENAC-NA | |
| IES950586A2 (en) | Pharmaceutical processing | |
| TW285640B (en) | ||
| AU1469097A (en) | Pharmaceutical compounds | |
| AU9437698A (en) | Compressed chloramine-t tablets and method for the production thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |